Medical Marijuana: US Patient Seeks Access to British Marijuana Extract Spray Through Investigational New Drug Program 7/1/05

Drug War Chronicle, recent top items

more...

recent blog posts "In the Trenches" activist feed

SUBSCRIBE TODAY!!!


http://stopthedrugwar.org/chronicle/393/sativex.shtml

Sativex, a prescription marijuana extract applied via sublingual spray manufactured by British drug company GW Pharmaceuticals, went on sale last week in Canada after being approved there earlier this year. This week, a Multiple Sclerosis victim from Illinois and her doctor announced they are seeking access to the drug through the US Food and Drug Administration's (FDA) Investigational New Drug (IND) program.

Under federal law, drugs that have been approved in another country but not yet in the US may be used under a doctor's direction if the FDA approves. Under a Compassionate Use IND, the US government has provided medical marijuana to a handful of patients for nearly 30 years, but has refused to accept any new patients into the program since 1992.

At a Wednesday press conference in Chicago, Julie Falco and her physician, Dr. Anthony Reder, backed by the medical marijuana defense organization Americans for Safe Access, unveiled the effort. "Patients in states that don't have laws allowing the medical use of marijuana need access to a safe and legal form of natural cannabis. Access to Sativex® will provide the pain relief I need without the threat of incarceration that hangs over all us all," said Falco, who said she uses marijuana to relieve the symptoms of MS.

The state of Illinois does not have a functioning medical marijuana program. A 33-year-old law allowed the state to create such a program, but it never did. This year, a group called IDEAL Reform came close to pushing a medical marijuana bill through the state legislature. But strong opposition that included a blitzkrieg visit to the statehouse by drug czar John Walters and campaigning against the bill -- and the very notion of medical marijuana -- by former deputy drug czar Andrea Barthwell helped kill the bill.

Marijuana is currently scheduled as a Schedule I drug, along with heroin and LSD, meaning it cannot be prescribed. The application to the IND is part of a larger strategy to reschedule marijuana in the US, said ASA executive director Steph Sherer in a statement Tuesday. "The introduction of Sativex® to Canadian markets vindicates what patients, doctors, and medical associations have been saying for centuries: marijuana is a safe and effective medication," said Sherer. "The bottom line is marijuana must be rescheduled so that we can have an honest conversation about the best uses of marijuana as medicine, including the introduction of Sativex® to the US market."

Falco will not be the only patient applying through the IND program for permission to use Sativex, said ASA. The group "will be assisting a number of MS patients and their doctors through this application process, while they continue in their quest to change the schedule of marijuana from its current status, in the same category as heroin, to another category that recognizes the medicinal value of marijuana."

GW Pharmaceuticals, meanwhile, has announced it will apply for FDA approval this year, a process that will take a minimum of three years. In a move that has caused shudders among drug reform activists, the British company has hired none other than the above-mentioned Andrea Barthwell to shepherd Sativex through the approval process.

-- END --
Link to Drug War Facts
Please make a generous donation to support Drug War Chronicle in 2007!          

PERMISSION to reprint or redistribute any or all of the contents of Drug War Chronicle (formerly The Week Online with DRCNet is hereby granted. We ask that any use of these materials include proper credit and, where appropriate, a link to one or more of our web sites. If your publication customarily pays for publication, DRCNet requests checks payable to the organization. If your publication does not pay for materials, you are free to use the materials gratis. In all cases, we request notification for our records, including physical copies where material has appeared in print. Contact: StoptheDrugWar.org: the Drug Reform Coordination Network, P.O. Box 18402, Washington, DC 20036, (202) 293-8340 (voice), (202) 293-8344 (fax), e-mail [email protected]. Thank you.

Articles of a purely educational nature in Drug War Chronicle appear courtesy of the DRCNet Foundation, unless otherwise noted.

Issue #393 -- 7/1/05

Drug War Chronicle, recent top items

more...

recent blog posts "In the Trenches" activist feed

SUBSCRIBE TODAY!!!

Editorial: Star Wars and the Drug War | Feature: Rhode Island Governor Vetoes Medical Marijuana Bill Wednesday -- Senate Overrides Thursday | Feature: Coca on the March in Peru | Feature: Most Marijuana Users in Drug Treatment Sent There By Criminal Justice System | Weekly: This Week's Corrupt Cops Stories | Global: World Drug Trade Worth $320 Billion Annually, UN Says | AIDS/HIV: Harm Reduction Wins Battle in UN AIDS Session | Asia: China Celebrates International Anti-Drugs Day with Executions, Bonfires | Hemp: Rep. Ron Paul Introduces Federal Bill for Industrial Hemp | Medical Marijuana: US Patient Seeks Access to British Marijuana Extract Spray Through Investigational New Drug Program | Africa: Cannabis Cultivation Feeds a Hundred Thousand Families in Morocco | Europe: British Marijuana Smokers Grow Their Own | Web Scan: Cato on Pain, MPP PSAs | Weekly: This Week in History | Job Opportunity: Harm Reduction Coalition, NYC | Weekly: The Reformer's Calendar

Mail this article to a friend
Send us feedback on this article
This issue -- main page
This issue -- single-file printer version
Drug War Chronicle -- main page
Chronicle archives
Subscribe now!
Out from the Shadows HEA Drug Provision Drug War Chronicle Perry Fund DRCNet en EspaŮol Speakeasy Blogs About Us Home
Why Legalization? NJ Racial Profiling Archive Subscribe Donate DRCNet em PortuguÍs Latest News Drug Library Search
special friends links: SSDP - Flex Your Rights - IAL - Drug War Facts

StoptheDrugWar.org: the Drug Reform Coordination Network (DRCNet)
1623 Connecticut Ave., NW, 3rd Floor, Washington DC 20009 Phone (202) 293-8340 Fax (202) 293-8344 [email protected]